237 related articles for article (PubMed ID: 30718275)
21. Establishment of the TALE-code reveals aberrantly activated homeobox gene PBX1 in Hodgkin lymphoma.
Nagel S; Pommerenke C; Meyer C; MacLeod RAF; Drexler HG
PLoS One; 2021; 16(2):e0246603. PubMed ID: 33539429
[TBL] [Abstract][Full Text] [Related]
22. Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer.
Liu L; Yao D; Zhang P; Ding W; Zhang X; Zhang C; Gong S; Zhang Y; Wang J; Sun T; Ren Z
Oncol Rep; 2017 Dec; 38(6):3531-3537. PubMed ID: 29130109
[TBL] [Abstract][Full Text] [Related]
23. Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.
Reiner T; Parrondo R; de Las Pozas A; Palenzuela D; Perez-Stable C
PLoS One; 2013; 8(2):e56234. PubMed ID: 23424652
[TBL] [Abstract][Full Text] [Related]
24. α-Synuclein fate is determined by USP9X-regulated monoubiquitination.
Rott R; Szargel R; Haskin J; Bandopadhyay R; Lees AJ; Shani V; Engelender S
Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18666-71. PubMed ID: 22065755
[TBL] [Abstract][Full Text] [Related]
25. [Silencing PBX1 expression induces apoptosis and ROS production of lung cancer cells].
Yao XP; Peng HX; Wu JR
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):843-848. PubMed ID: 33113625
[No Abstract] [Full Text] [Related]
26. A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer.
Chen X; Yu C; Gao J; Zhu H; Cui B; Zhang T; Zhou Y; Liu Q; He H; Xiao R; Huang R; Xie H; Gao D; Zhou H
Theranostics; 2018; 8(9):2348-2360. PubMed ID: 29721084
[TBL] [Abstract][Full Text] [Related]
27. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
[TBL] [Abstract][Full Text] [Related]
28. Deubiquitinase USP9X stabilizes RNA m
Wang P; Wang J; Yao S; Cui M; Cheng Y; Liu W; Gao Z; Hu J; Zhang J; Zhang H
J Biol Chem; 2023 Aug; 299(8):105055. PubMed ID: 37454738
[TBL] [Abstract][Full Text] [Related]
29. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ
Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533
[TBL] [Abstract][Full Text] [Related]
30. USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.
Kushwaha D; O'Leary C; Cron KR; Deraska P; Zhu K; D'Andrea AD; Kozono D
Cancer Biol Ther; 2015; 16(3):392-401. PubMed ID: 25692226
[TBL] [Abstract][Full Text] [Related]
31. Deubiquitinating enzyme USP9X regulates metastasis and chemoresistance in triple-negative breast cancer by stabilizing Snail1.
Guan T; Yang X; Liang H; Chen J; Chen Y; Zhu Y; Liu T
J Cell Physiol; 2022 Jul; 237(7):2992-3000. PubMed ID: 35506169
[TBL] [Abstract][Full Text] [Related]
32. USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle.
Song N; Deng L; Zeng L; He L; Liu C; Liu L; Fu R
Mol Carcinog; 2023 Oct; 62(10):1487-1503. PubMed ID: 37314216
[TBL] [Abstract][Full Text] [Related]
33. A hydrophobic residue in the TALE homeodomain of PBX1 promotes epithelial-to-mesenchymal transition of gastric carcinoma.
He C; Wang Z; Zhang L; Yang L; Li J; Chen X; Zhang J; Chang Q; Yu Y; Liu B; Zhu Z
Oncotarget; 2017 Jul; 8(29):46818-46833. PubMed ID: 28514754
[TBL] [Abstract][Full Text] [Related]
34. Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction.
Gomez-Bougie P; Ménoret E; Juin P; Dousset C; Pellat-Deceunynck C; Amiot M
Biochem Biophys Res Commun; 2011 Sep; 413(3):460-4. PubMed ID: 21907705
[TBL] [Abstract][Full Text] [Related]
35. In vitro analysis of proteasome-associated USP14 activity for substrate degradation and deubiquitylation.
Muniyappan S; Lee BH
Methods Enzymol; 2019; 619():249-268. PubMed ID: 30910023
[TBL] [Abstract][Full Text] [Related]
36. Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment.
Gao H; Chen Z; Zhao L; Ji C; Xing F
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189099. PubMed ID: 38582329
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo.
Karpel-Massler G; Banu MA; Shu C; Halatsch ME; Westhoff MA; Bruce JN; Canoll P; Siegelin MD
Oncotarget; 2016 Mar; 7(11):12791-805. PubMed ID: 26872380
[TBL] [Abstract][Full Text] [Related]
38. DDX3 interacts with USP9X and participates in deubiquitination of the anti-apoptotic protein MCL1.
Lai MC; Chen YP; Li DA; Yu JS; Hung HY; Tarn WY
FEBS J; 2022 Feb; 289(4):1043-1061. PubMed ID: 34606682
[TBL] [Abstract][Full Text] [Related]
39. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
[TBL] [Abstract][Full Text] [Related]
40. USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification.
Nielsen CP; Jernigan KK; Diggins NL; Webb DJ; MacGurn JA
Cell Rep; 2019 Jul; 28(4):1074-1089.e5. PubMed ID: 31340145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
